MICHAEL KOONTZ, MD
Internal Medicine Physician · MONTEREY, CA
Individual Active NPI 1245410588
Medicare payment data Part B · 2024
| Year | Beneficiaries | Services | Submitted | Allowed | Paid |
|---|---|---|---|---|---|
| 2024 | 1,086 | 235,858 | $12,453,022 | $4,888,992 | $3,890,123 |
| 2023 | 905 | 180,497 | $9,395,303 | $3,591,531 | $2,850,364 |
| 2022 | 826 | 150,290 | $7,672,852 | $2,932,122 | $2,325,615 |
Top procedures (2024)
| HCPCS | Description | Services | Avg allowed | Avg paid |
|---|---|---|---|---|
| J1439 | Injection, ferric carboxymaltose, 1 mg | 42,000 | $1 | $1 |
| J0881 | Injection, darbepoetin alfa, 1 microgram (non-esrd use) | 19,641 | $3 | $2 |
| J1442 | Injection, filgrastim (g-csf), excludes biosimilars, 1 microgram | 18,480 | $1 | $1 |
| J9271 | Injection, pembrolizumab, 1 mg | 15,000 | $56 | $45 |
| J9263 | Injection, oxaliplatin, 0.5 mg | 11,320 | $0 | $0 |
| J0897 | Injection, denosumab, 1 mg | 9,300 | $26 | $21 |
| J9144 | Injection, daratumumab, 10 mg and hyaluronidase-fihj | 9,000 | $49 | $39 |
| J9267 | Injection, paclitaxel, 1 mg | 8,561 | $0 | $0 |
| J1453 | Injection, fosaprepitant, 1 mg | 3,900 | $0 | $0 |
| J9171 | Injection, docetaxel, 1 mg | 3,124 | $1 | $1 |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | 3,020 | $0 | $0 |
| Q5107 | Injection, bevacizumab-awwb, biosimilar, (mvasi), 10 mg | 2,960 | $26 | $21 |
Taxonomy & licensure
| Specialty | Code | Primary | License | State |
|---|---|---|---|---|
| Internal Medicine Physician | 207R00000X | ✓ | A105130 | CA |
Medicare eligibility
- Part B
- Yes
- DME
- Yes
- Home health
- Yes
- Power mobility
- Yes
- Hospice
- Yes
Other Internal Medicine Physician providers in California
- NPI 1093034530
- NPI 1740612068
- NPI 1891711529
- NPI 1235127564
- NPI 1912098534
- NPI 1598866162
- NPI 1639129901
- NPI 1568844637
See all Internal Medicine Physician providers in California →
Source: NPPES (public domain) and CMS Medicare Physician & Other Practitioners data. Not affiliated with CMS, NPPES, or any government agency.